Check KUOW’s “Weekday” for Science News
Luke Timmerman
Science news often falls into the trap of becoming “infotainment” designed to generate ratings, and little else. As one essayist in The Guardian recently ...
Matrix Genetics Emerges from Algae Biofuel Wilderness With a Partner
Luke Timmerman
Matrix Genetics is one of those startups that never really got off the ground in its early days, but never died, either. While the Seattle-based company lived ...
Genentech Follows Fast at ASCO as Cancer Immunotherapy Picks Up
Luke Timmerman
Genentech made its name in cancer by creating targeted antibody drugs that zero in on tumor cells while mostly sparing healthy tissue. Now it’s seeking to ...
Genentech Cancer Antibody, Son of Rituxan, Nails Pivotal Study
View the Slideshow Luke Timmerman
Genentech has been searching for years to find a way to improve upon rituximab (Rituxan), which set a gold standard 15 years ago as part of ...
Henri Termeer on Startups, Drug Prices, Getting Older (Part 2)
Luke Timmerman
Yesterday, we ran the first part of a wide-ranging interview with Henri Termeer, the legendary biotech entrepreneur and former CEO of Cambridge, MA-based Genzyme. ...
Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
Luke Timmerman
Henri Termeer could have easily faded away into obscurity a couple years ago. The biotech pioneer could have relaxed at his oceanside home in Maine, played ...
Dunsire Out at Millennium as Takeda Reorganizes, Cuts Costs
Luke Timmerman
[Updated: 10:25 pm ET] Deborah Dunsire, the CEO who led Millennium Pharmaceuticals to prominence in cancer treatment, is leaving the company in an abrupt departure ...
Dendreon Shares Fall Again, as Provenge Sales Slump
Luke Timmerman
Dendreon has made a habit of disappointing investors, and it did so again today.
The Seattle-based biotech company (NASDAQ: DNDN) said today it generated $67.6 ...
Genomic Health Test Aims To Cut Overtreatment of Prostate Cancer
Luke Timmerman
Many men in the U.S. hear the words “prostate cancer” and freak out. They want to fight. But a lot of times, the aggressive treatments they demand are unnecessary, ...
Lessons For Drug Development From The Aveo Buzzsaw
Luke Timmerman
Drug development is a tough business. Small companies that dare to try often end up in public train wrecks when they head to Washington to meet the FDA. It’s ...